Vaftor

Vaftor (ivacaftor) is a prescription oral medication used to manage cystic fibrosis symptoms by improving lung function. It belongs to the CFTR modulator class and is taken as directed by a healthcare provider. Suitable for adults and children with specific genetic mutations.

Vaftor is used to treat cystic fibrosis in patients aged 4 months and older who have certain mutations in the CFTR gene. It helps improve lung function and reduce symptoms like breathing difficulties and frequent lung infections. This medication works by helping the CFTR protein function better, which is crucial for proper fluid movement in the lungs.

Vaftor may help reduce the frequency of respiratory symptoms and improve overall lung function in people with cystic fibrosis. Some users report better exercise tolerance and fewer hospitalizations related to lung issues. It does not cure cystic fibrosis but aims to manage symptoms and slow disease progression.

Vaftor should be taken exactly as prescribed by a healthcare provider. Inform your doctor about all medications and supplements you are using, including over-the-counter products. Regular monitoring, including liver function tests, may be required while taking this medication. Keep this medication stored in a cool, dry place away from direct sunlight.

Vaftor can interact with certain medications, including strong CYP3A inhibitors or inducers, which may affect its effectiveness or increase side effects. Grapefruit products may also interact with ivacaftor. Always consult your healthcare provider before combining Vaftor with other drugs, especially antibiotics or antifungals.